Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Genitourinary Drugs Companies

ID: MRFR/Pharma/5338-HCR
85 Pages
Rahul Gotadki
Last Updated: February 16, 2025
Genitourinary Drugs companies focus on advancing therapies for urinary and reproductive health. Through dedicated research, development, and distribution, these organizations provide innovative medications, contributing to improved outcomes for individuals dealing with genitourinary disorders.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Genitourinary Drugs Market
Market Size
Forecast Period2026-2035
CAGR (2026-2035)1.72%
2025 Market SizeUSD 32.28 Billion
2035 Market SizeUSD 38.29 Billion
Key Players
Pfizer Inc.
Astellas Pharma
AbbVie Inc.
Johnson & Johnson
Eli Lilly & Co.
Bayer AG
Opportunities
  • Gene and Cell Therapies for Overactive Bladder
  • Emerging-Market Urology Infrastructure Expansion
  • Digital Therapeutics and Companion Diagnostics

Top Industry Leaders in the Genitourinary Drugs Market

Genitourinary Drugs Market
 

Latest Genitourinary Drugs Companies Updates:

Pfizer's Xtandi Approval: Pfizer secured FDA approval for Xtandi's expanded use in treating prostate cancer, potentially boosting their market share.

Johnson & Johnson's Spravato Expansion: J&J received FDA approval for Spravato (esketamine) as a maintenance treatment for depression, potentially opening up new avenues for the drug.

AstraZeneca's Lynparza Milestone: AstraZeneca announced Lynparza achieved blockbuster status, generating over $1 billion in annual sales for ovarian cancer treatment.

List of Genitourinary Drugs companies in the market:

  • Abbott
  • Astellas Pharma Inc.
  • AstraZeneca
  • Pfizer Inc.
  • Eli Lilly and Company
  • Genentech, Inc.
  • Immunex Corp.
  • GlaxoSmithKline plc.
  • Ionis Pharmaceuticals
  • Merck & Co., Inc.
  • Novartis AG